Red ginseng is steamed Panax ginseng root. Modest, setting-specific effects—not a proven lengthening of human life. The clearest signals are improved erectile function in small, often low-quality trials and less chemotherapy-related fatigue. Harms at 1–3 g/day are usually gut symptoms and sleep disruption. Pregnancy, transplant anti-rejection drugs, untested sexual-enhancement blends, and possibly autoimmune disease are the main avoidance settings. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting plasma glucose | 70–85 mg/dL (functional); conventional fasting <100 mg/dL | Detects glucose-lowering and hypoglycemia risk |
| HbA1c | <5.3% (functional); conventional <5.7% | 3-month glucose average; trials showed little movement |
| Systolic / diastolic blood pressure | ~110–120 / 70–80 mmHg seated | Tracks both reported drops and paradoxical rises |
| LDL-cholesterol | <80 mg/dL (functional); many labs flag ≥100 mg/dL | Small lipid signal in Panax meta-analysis |
| INR (if on warfarin) | Target set by the anticoagulation indication (often 2.0–3.0) | Detects clotting-test drift |
| Complete blood count | Track change from personal baseline; no unique ginseng target | Optional when immune-cell claims are the goal |
Cadence: Baseline before a course; repeat the same panel after 4–8 weeks, then every 3–6 months if use continues. Recheck INR 3–7 days after start or stop if on warfarin.